Join to View Full Profile
282 Washington StConnecticut Childrens Specialty GroupHartford, CT 06106
Phone+1 860-545-9000
Dr. Ionita is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Clinical Expertise
- Neuromuscular medicine, Child neurology, General neurology, Movement disorders, Headache disorders
Education & Training
SUNY Downstate Health Sciences UniversityFellowship, Child Neurology, 2002 - 2005- SUNY Downstate Health Sciences UniversityResidency, Pediatrics, 1999 - 2002
Carol Davila University of Medicine and PharmacyClass of 1997
Certifications & Licensure
CT State Medical License 2010 - 2025
WA State Medical License 2014 - 2016
AR State Medical License 2005 - 2010
American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology- American Board of Psychiatry and Neurology Neuromuscular Medicine
Clinical Trials
- A Study to Assess the Safety and Tolerability of Nusinersen (ISIS 396443) in Participants With Spinal Muscular Atrophy (SMA). Start of enrollment: 2015 Aug 19
Publications & Presentations
PubMed
- 5 citationsSpinal Muscular Atrophy Update in Best Practices: Recommendations for Diagnosis Considerations.Mary Schroth, Jennifer Deans, Kapil Arya, Diana Castro, Darryl C De Vivo
Neurology. Clinical Practice. 2024-08-01 - 2 citationsBiallelic CRELD1 variants cause a multisystem syndrome, including neurodevelopmental phenotypes, cardiac dysrhythmias, and frequent infections.Lauren Jeffries, Emily K Mis, Kirsty McWalter, Sandra Donkervoort, Nina N Brodsky
Genetics in Medicine. 2024-02-01 - The Impact of COVID-19 on Families With Pediatric Muscular Dystrophy Patients.Adeel S Zubair, Kirsten Scharer, Paige Lembeck, Cristian Ionita, Bhaskar Roy
Cureus. 2023-06-01
Press Mentions
Collective Statement Regarding Patient Access to Approved Therapies from the Center Directors of Parent Project Muscular Dystrophy’s Certified Duchenne Care CentersMarch 15th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
